These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36222770)

  • 1. Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Pantelyat A
    Continuum (Minneap Minn); 2022 Oct; 28(5):1364-1378. PubMed ID: 36222770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
    JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep disturbances in progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS).
    Alster P; Madetko-Alster N; Migda A; Migda B; Kutyłowski M; Królicki L; Friedman A
    Neurol Neurochir Pol; 2023; 57(3):229-234. PubMed ID: 36928793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome.
    Satoh R; Weigand SD; Pham NTT; Ali F; Arani A; Senjem ML; Jack CR; Whitwell JL; Josephs KA
    Mov Disord; 2023 Dec; 38(12):2282-2290. PubMed ID: 37772771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of Skin α-Synuclein Deposits Discriminates Parkinson's Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Giannoccaro MP; Avoni P; Rizzo G; Incensi A; Infante R; Donadio V; Liguori R
    J Parkinsons Dis; 2022; 12(2):585-591. PubMed ID: 34864689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson's disease (PD).
    Swallow DMA; Counsell CE
    J Neurol; 2023 Jul; 270(7):3464-3474. PubMed ID: 36971841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinsonism.
    Keener AM; Bordelon YM
    Semin Neurol; 2016 Aug; 36(4):330-4. PubMed ID: 27643900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis.
    Lyons S; Trépel D; Lynch T; Walsh R; O'Dowd S
    J Neurol; 2023 Sep; 270(9):4451-4465. PubMed ID: 37289323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Coughlin DG; Dickson DW; Josephs KA; Litvan I
    Adv Exp Med Biol; 2021; 1281():151-176. PubMed ID: 33433875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations.
    Eusebio A; Koric L; Félician O; Guedj E; Ceccaldi M; Azulay JP
    Rev Neurol (Paris); 2016; 172(8-9):488-502. PubMed ID: 27561438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.
    Boman A; Svensson S; Boxer A; Rojas JC; Seeley WW; Karydas A; Miller B; Kågedal K; Svenningsson P
    J Parkinsons Dis; 2016 Apr; 6(2):307-15. PubMed ID: 27061067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progressive supranuclear palsy: what's new?].
    Levy R
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):191-201. PubMed ID: 21690028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy.
    Bruns MB; Josephs KA
    Int Rev Psychiatry; 2013 Apr; 25(2):197-209. PubMed ID: 23611349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome.
    Chung EJ; Cho HJ; Jang W; Hur DY; Kim YS; Lee KH; Kim SJ
    J Korean Med Sci; 2022 Jun; 37(22):e183. PubMed ID: 35668689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.
    Bluett B; Pantelyat AY; Litvan I; Ali F; Apetauerova D; Bega D; Bloom L; Bower J; Boxer AL; Dale ML; Dhall R; Duquette A; Fernandez HH; Fleisher JE; Grossman M; Howell M; Kerwin DR; Leegwater-Kim J; Lepage C; Ljubenkov PA; Mancini M; McFarland NR; Moretti P; Myrick E; Patel P; Plummer LS; Rodriguez-Porcel F; Rojas J; Sidiropoulos C; Sklerov M; Sokol LL; Tuite PJ; VandeVrede L; Wilhelm J; Wills AA; Xie T; Golbe LI
    Front Neurol; 2021; 12():694872. PubMed ID: 34276544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome.
    Whiteside DJ; Street D; Murley AG; Jones PS; Malpetti M; Ghosh BCP; Coyle-Gilchrist I; Gerhard A; Hu MT; Klein JC; Leigh PN; Church A; Burn DJ; Morris HR; Rowe JB; Rittman T
    Hum Brain Mapp; 2023 Aug; 44(11):4239-4255. PubMed ID: 37269181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
    Fabbrini G; Fabbrini A; Suppa A
    Handb Clin Neurol; 2019; 165():155-177. PubMed ID: 31727210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.